PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11250874-9	2001	In 300 nM U46619-precontracted arteries, pretreatment with either 100 nM charybdotoxin or 100 nM iberiotoxin or 10 nM felodipine significantly (P<0.05) attenuated the CGRP-induced reduction in both [Ca(2+)](i) and tension.	Charybdotoxin	73-86	calcitonin-related polypeptide alpha	Rattus norvegicus	170-174	
11250874-12	2001	In resting coronary arteries, only pretreatment with the combination of 1 microM glibenclamide and 100 nM charybdotoxin attenuated the CGRP-induced decrease in the [Ca(2+)](i) and tension, suggesting a different mechanism of action for CGRP in resting coronary arteries.	Charybdotoxin	106-119	calcitonin-related polypeptide alpha	Rattus norvegicus	135-139	
11250874-12	2001	In resting coronary arteries, only pretreatment with the combination of 1 microM glibenclamide and 100 nM charybdotoxin attenuated the CGRP-induced decrease in the [Ca(2+)](i) and tension, suggesting a different mechanism of action for CGRP in resting coronary arteries.	Charybdotoxin	106-119	calcitonin-related polypeptide alpha	Rattus norvegicus	236-240	
8769767-5	1996	Vasodilation and increase in cAMP production evoked by CGRP were inhibited not only by glibenclamide (ATP-sensitive K+ channel blocker) but also by charybdotoxin (large-conductance Ca(2+)-activated K+ channel blocker), but this was not the case for the isoproterenol-induced vasodilation and cAMP production.	Charybdotoxin	148-161	calcitonin-related polypeptide alpha	Rattus norvegicus	55-59